[Treatment of marked epithelial dysplasia of esophagus. II. Microspectophotometric studies on DNA content in epithelial cells of esophagus treated with antitumor B III or tilorone (author's transl)].
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000032:analysis*; D004338:Drug Combinations / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal; D004848:Epithelium / Q000032:analysis; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D004947:Esophagus / Q000032:analysis; D005449:Fluorenes / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use*; D006801:Humans; D010936:Plant Extracts / Q000627:therapeutic use*; D011230:Precancerous Conditions / Q000188:drug therapy; D013053:Spectrophotometry; D013994:Tilorone / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; C027129:Antitumor B III; D004273:DNA, Neoplasm; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; D005449:Fluorenes; D010936:Plant Extracts; D013994:Tilorone; D005472:Fluorouracil